Related Experiment Video
Updated: Oct 8, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
766
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
Somayeh Vafaei1, Angelina O Zekiy2, Ramadhan Ado Khanamir3
1Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Cancer Cell International
|January 4, 2022
Summary
Immune checkpoint inhibitors (ICIs) show promise but face resistance and toxicity. Combining ICIs with other therapies may overcome resistance and improve anti-tumor effects in cancer treatment.
Area of Science:
- Oncology
- Immunotherapy
Background:
- Immune checkpoint inhibitors (ICIs) offer durable anti-tumor effects but face challenges with resistance and toxicity.
- Approximately 60-70% of patients with melanoma and lung cancer do not respond to ICIs.
- Tumor microenvironment alterations contribute to ICI resistance by promoting angiogenesis and inhibiting anti-tumor immunity.
Purpose of the Study:
- To review the therapeutic benefits of ICIs in cancer immunotherapy.
- To explore the impact of combining ICIs with other treatment modalities to overcome resistance.
Main Methods:
- Literature review of studies on ICIs and combination therapies.
- Analysis of mechanisms underlying ICI resistance, focusing on the tumor microenvironment.
Main Results:
- ICIs represent a significant advancement in cancer immunotherapy.
- Combination strategies involving ICIs with chemoradiotherapy, targeted therapies, or cancer vaccines show potential to enhance efficacy.
- Addressing tumor microenvironment-mediated resistance is crucial for improving ICI response rates.
Conclusions:
- Combination therapy holds promise for overcoming ICI resistance and improving patient outcomes.
- Further research into optimizing combination strategies is warranted to maximize the clinical utility of ICIs.
Related Concept Videos
01:27Tumor Immunotherapy
719
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
719
02:50Combination Therapies and Personalized Medicine
5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
01:30Cancer Vaccines
547
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
547
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
282
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
282